Clinical Content All Posts Patient Empowerment Success Stories Science & Technology Jul 3, 2024 When PrismRA can help guide treatment decisions: intended use & case study examples PrismRA is intended to be used by the treating physician when considering starting, adjusting the do... Read More Jun 15, 2024 PrismRA Was Developed & Clinically Validated to Guide RA Therapy Selection PrismRA® is a blood-based precision medicine test that was developed using the science of the human ... Read More May 15, 2024 Examining the Clinical Utility of PrismRA PrismRA® is a blood-based precision medicine test used by over 1,400 advanced practitioners around t... Read More Apr 30, 2024 Current Care Therapy Selection for RA Relies on Trial-and-Error Rheumatoid arthritis (RA) affects roughly 1.6 million people in the US and as much as 1% of the popu... Read More Jul 3, 2024 When PrismRA can help guide treatment decisions: intended use & case study examples PrismRA is intended to be used by the treating physician when considering starting, adjusting the do... Read More May 15, 2024 Examining the Clinical Utility of PrismRA PrismRA® is a blood-based precision medicine test used by over 1,400 advanced practitioners around t... Read More Jun 15, 2024 PrismRA Was Developed & Clinically Validated to Guide RA Therapy Selection PrismRA® is a blood-based precision medicine test that was developed using the science of the human ... Read More May 15, 2024 Examining the Clinical Utility of PrismRA PrismRA® is a blood-based precision medicine test used by over 1,400 advanced practitioners around t... Read More Apr 30, 2024 Current Care Therapy Selection for RA Relies on Trial-and-Error Rheumatoid arthritis (RA) affects roughly 1.6 million people in the US and as much as 1% of the popu... Read More Learn More About PrismRA Interested in how PrismRA helps guide therapy decisions? Please contact the Scipher Medicine Client Services team. Support@Scipher.com 855-724-7437 Contact Us Learn more about Scipher Medicine’s mission Join Newsletter